Related Experiment Video
Updated: Jul 9, 2025

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
4.0K
[Diabetes and women, why are we different?]
M P Pérez Unanua1, F López Simarro2, C I Novillo López3
1Medicina de Familia, Centro de Salud Dr. Castroviejo, Madrid, España.
Semergen
|December 5, 2023
Summary
Diabetes impacts women and men differently, necessitating tailored clinical approaches. Understanding these gender-specific differences is crucial for accurate diagnosis and effective diabetes management in women.
Area of Science:
- Endocrinology
- Women's Health
- General Practice
Context:
- Diabetes mellitus presents distinct clinical manifestations and management challenges between sexes.
- The assumption of gender equality in diabetes care can lead to diagnostic and therapeutic delays.
- Women experience unique physiological changes impacting glycemic control throughout their lives.
Purpose:
- To elucidate gender-specific differences in diabetes presentation and management.
- To highlight the critical role of family physicians in monitoring women with diabetes.
- To review the literature on sex-based variations in diabetes care.
Summary:
- This review examines how hormonal fluctuations influence glycemic control in women.
- It addresses gestational diabetes and its implications.
- The study analyzes sex-based differences in chronic complication development, cardiovascular risk factor control, and pharmacotherapy for diabetes.
Impact:
- Informed clinical practice for improved diabetes outcomes in women.
- Enhanced understanding of gender-based nuances in diabetes pathophysiology and treatment.
- Guidance for family physicians on sex-specific diabetes monitoring and care strategies.
Keywords:
Cardiovascular riskDiabetes mellitusDiferencias sexualesMujerRiesgo cardiovascularSex differencesWomenMore Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Insulin: Dosing Regimen and Adverse Effects
181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181

